These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1153625)

  • 21. Striatal dopamine and motor activity changes observed shortly after lithium administration.
    Otero Losada ME; Rubio MC
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):169-74. PubMed ID: 2865683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated exposure of rats to the convulsant agent flurothyl enhances 5-hydroxytryptamine- and dopamine-mediated behavioural responses.
    Green AR
    Br J Pharmacol; 1978 Mar; 62(3):325-31. PubMed ID: 638311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.
    Heal DJ; Green AR; Boullin DJ; Grahame-Smith DG
    Psychopharmacology (Berl); 1976 Sep; 49(3):287-300. PubMed ID: 12527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of in vitro amine uptake into rat brain synaptosomes after in vivo administration of antidepressants.
    Manias B; Taylor DA
    Eur J Pharmacol; 1983 Nov; 95(3-4):305-9. PubMed ID: 6653676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional concentrations of cerebral amines: effects of tranylcypromine and phenelzine.
    McKim RH; Calverly DG; Dewhurst WG; Baker GB
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):783-6. PubMed ID: 6141618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of levels of biogenic amines and their metabolites and both forms of monoamine oxidase in prefrontal cortex of aged rats.
    Venero JL; Machado A; Cano J
    Mech Ageing Dev; 1990 Dec; 56(3):253-63. PubMed ID: 2089199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of long-term administration of rubidium or lithium on reactivity to stress and on dopamine output in the nucleus accumbens in rats.
    Gambarana C; Ghiglieri O; Masi F; Scheggi S; Tagliamonte A; De Montis MG
    Brain Res; 1999 May; 826(2):200-9. PubMed ID: 10224297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of lithium and rubidium on the sleeping time caused by various intravenous anaesthetics in the mouse.
    Männistö PT; Saarnivaara L
    Br J Anaesth; 1976 Mar; 48(3):185-9. PubMed ID: 1259882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of lithium and rubidium on exploratory behaviour and locomotor activity in isolated male mice (author's transl)].
    Weischer ML
    Psychopharmacology (Berl); 1979 Mar; 61(3):263-6. PubMed ID: 109890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-(2-cyanoethyl)tranylcypromine, a potential prodrug of tranylcypromine: its disposition and interaction with catecholamine neurotransmitters in brain.
    Nazarali AJ; Baker GB; Coutts RT; Wong TF
    Pharm Res; 1987 Feb; 4(1):16-20. PubMed ID: 3508523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chronic lithium treatment on brain monoamine metabolism and amphetamine-induced locomotor stimulation in rats.
    Berggren U
    J Neural Transm; 1985; 64(3-4):239-50. PubMed ID: 4086991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chronic LiCl and RbCl on muricide induced by midbrain raphe lesions in rats.
    Yamamoto T; Araki H; Abe Y; Ueki S
    Pharmacol Biochem Behav; 1985 Apr; 22(4):559-63. PubMed ID: 2986181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase.
    Palfreyman MG; Mir AK; Kubina M; Middlemiss DN; Richards M; Tricklebank MD; Fozard JR
    Eur J Pharmacol; 1986 Oct; 130(1-2):73-89. PubMed ID: 3780861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lanthanides inhibit the human noradrenaline, 5-hydroxytryptamine and dopamine transporters.
    Bryan-Lluka LJ; Bönisch H
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):699-706. PubMed ID: 9205953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity.
    Dolphin A; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Oct; 5(4):431-9. PubMed ID: 1005491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Piperidine: effects on locomotor activity and brain monoamine turnover.
    Alm B
    Psychopharmacology (Berl); 1976 Nov; 50(3):301-4. PubMed ID: 826977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain amine concentrations after monoamine oxidase inhibitor administration.
    Jones AB; Pare CM; Nicholson WJ; Price K; Stacey RS
    Br Med J; 1972 Jan; 1(5791):17-9. PubMed ID: 5008339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.
    Evans JP; Grahame-Smith DG; Green AR; Tordoff AF
    Br J Pharmacol; 1976 Feb; 56(2):193-9. PubMed ID: 3248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.